Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Bo Didley who wrote (2695)	10/23/2000 2:39:56 PM
From: Bo Didley	Respond to of 5582

Nicotine Gum + Zicam Good buisnesses for long term investors. A few of us know about the medical success of Zicam and penetrating the $3 billion otc common cold market further and further each year. As it penetrates further each year, more investors are coming on board as they learn about Zicam. Here is info on the up coming Nicotine Gum Message 14633288 Ignore all the short and distort messages from shorts who just started their research. Compare it to those of us here who have analyzed the company and products for a couple of years. bo